Orbis Medicines

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery. Its platform delivers macrocycle candidates, termed nCycles. These are optimized for oral bioavailability, which has historically hindered therapeutic development of this versatile class of molecules. The company's pipeline is initially focused on nCycle candidates against targets validated by blockbuster biologic drugs delivered by injection.

Domain

orbismedicines.com

Country

Germany

Industry

Health Care

Employees

1-10

Last Funding

$93.5M

Founded

2020

Frequently Asked Questions

What technologies does Orbis Medicines use?+

Orbis Medicines uses 14 technologies including Adobe Fonts, Google Analytics, Google Tag Manager.

What industry is Orbis Medicines in?+

Orbis Medicines operates in the Health Care industry.

Where is Orbis Medicines based?+

Orbis Medicines is headquartered in Germany.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026